IBUPROFEN AND DIPHENHYDRAMINE CITRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ibuprofen And Diphenhydramine Citrate, and what generic alternatives are available?
Ibuprofen And Diphenhydramine Citrate is a drug marketed by Aurobindo Pharma, Dr Reddys Labs Ltd, Perrigo R And D, and Pld Acquisitions Llc. and is included in four NDAs.
The generic ingredient in IBUPROFEN AND DIPHENHYDRAMINE CITRATE is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?
- What are the global sales for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?
- What is Average Wholesale Price for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?
Summary for IBUPROFEN AND DIPHENHYDRAMINE CITRATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 28 |
| Clinical Trials: | 2 |
| DailyMed Link: | IBUPROFEN AND DIPHENHYDRAMINE CITRATE at DailyMed |
Recent Clinical Trials for IBUPROFEN AND DIPHENHYDRAMINE CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dr. Reddy's Laboratories Limited | Phase 1 |
See all IBUPROFEN AND DIPHENHYDRAMINE CITRATE clinical trials
Pharmacology for IBUPROFEN AND DIPHENHYDRAMINE CITRATE
| Drug Class | Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for IBUPROFEN AND DIPHENHYDRAMINE CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 216204-001 | May 31, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pld Acquisitions Llc | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 211404-001 | Apr 11, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Ltd | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 090619-001 | Jul 8, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo R And D | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 079113-001 | Dec 22, 2008 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
